Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

Lisa Giulino-RothDepartment of Pediatrics, Weill Cornell Medical College, New York, NY, USA; ;Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Correspondence[email protected]

Tara O’DonohueDepartment of Pediatrics, Weill Cornell Medical College, New York, NY, USA; ;Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Zhengming ChenDivision of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA;

Tanya M. TrippettDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Elizabeth KleinDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Nancy A. KernanDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Rachel KobosDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Susan E. ProckopDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Andromachi ScaradavouDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Neerav ShuklaDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Peter G. SteinherzDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

Alison J. MoskowitzDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Craig H. MoskowitzDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Farid BouladDepartment of Pediatrics, Weill Cornell Medical College, New York, NY, USA; ;Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Correspondence[email protected]

show all

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

ICMJE Form for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

ICMJE Form for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date